ICU · Electrolytes
Electrolyte Disorders in Critical Illness — Sodium, Potassium, Calcium, Magnesium and Phosphate
Also known as Dysnatraemia · Hyponatraemia · Hypernatraemia · Hyperkalaemia · Hypokalaemia · Electrolyte disturbances
Electrolyte disorders are among the commonest and most immediately dangerous derangements in critical illness, and their correction is governed less by the absolute concentration than by the speed and direction of change. This topic builds the examiner's framework around the two highest-yield cations — sodium and potassium — and a concise account of calcium, magnesium and phosphate. For sodium, the central ideas are that hyponatraemia is a disorder of water handling classified by osmolality and volume status, that the dangerous consequences are cerebral oedema (acute) and osmotic demyelination (over-correction), and that the rate of correction is the single most important decision. For potassium, the central ideas are that hyperkalaemia with ECG change is an emergency treated in a fixed sequence, and that hypokalaemia is a product of redistribution or total-body deficit. The evidence base is anchored on the Adrogué NEJM reviews of dysnatraemia, the Verbalis expert-panel hyponatraemia recommendations, the Kovesdy and Palmer potassium reviews, and the Ayuk hypomagnesaemia review, with the calcium and phosphate content resting on the standard ICU texts.
Checked against its sources on 1 Sept 2026
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Meet the patient
A 64-year-old woman on a thiazide arrives after a generalised seizure, drowsy and confused — sodium 108, serum osmolality 248, urine sodium 60 with a urine osmolality of 420. In the next bed a septic diabetic with an acute kidney injury has a potassium of 7.1 and a QRS that is widening into a sine wave on the monitor.[3]
Two questions will decide whether both patients survive the next hour, and they are the two that decide every electrolyte emergency: how fast may I move this number? — the sodium, where speed kills the chronically adapted brain — and what is the fixed sequence? — the potassium, where order is everything. Hold those two questions and the whole topic falls into place.[4]
References43ShowHide
- [1]Adrogué HJ, Madias NE. Hyponatremia N Engl J Med, 2000.PMID 10824078
- [2]Adrogué HJ, Madias NE. Hypernatremia N Engl J Med, 2000.PMID 10816188
- [3]Verbalis JG, Goldsmith SR, Greenberg A, et al. Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations Am J Med, 2013.PMID 24074529
- [4]Kovesdy CP. Management of hyperkalaemia in chronic kidney disease Nat Rev Nephrol, 2014.PMID 25223988
- [5]Clase CM, Carrero JJ, Ellison DH, et al. Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference Kidney Int, 2020.PMID 31706619
- [6]Ayuk J, Gittoes NJ. Treatment of hypomagnesemia Am J Kidney Dis, 2014.PMID 24100128
- [7]Sterns RH, Nigwekar SU, Hix JK. The treatment of hyponatremia Semin Nephrol, 2009.PMID 19523575
- [8]Sterns RH, Silver SM. Complications and management of hyponatremia Curr Opin Nephrol Hypertens, 2016.PMID 26735146
- [9]Liamis G, Kalogirou M, Saugos V, et al. Therapeutic approach in patients with dysnatraemias Nephrol Dial Transplant, 2006.PMID 16449285
- [10]Hillier TA, Abbott RD, Barrett EJ. Hyponatremia: evaluating the correction factor for hyperglycemia Am J Med, 1999.PMID 10225241
- [11]da Silva JSV, Seres DS, Sabino K, et al. ASPEN Consensus Recommendations for Refeeding Syndrome Nutr Clin Pract, 2020.PMID 32115791
- [12]Amanzadeh J, Reilly RF. Hypophosphatemia: an evidence-based approach to its clinical consequences and management Nat Clin Pract Nephrol, 2006.PMID 16932412
- [13]El-Hajj Fuleihan G, Clines GA, Hu MI, et al. Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline J Clin Endocrinol Metab, 2023.PMID 36545746
- [14]Bidar F, Chardon N, Darnajoux Q, et al. Clinical and biological profiles associated with the time of occurrence of citrate accumulation in patients receiving continuous renal replacement therapy Crit Care, 2025.PMID 41013710
- [15]Yunos NM, Bellomo R, Hegarty C, et al. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults JAMA, 2012.PMID 23073953
- [16]Semler MW, Self WH, Rice TW Balanced Crystalloids versus Saline in Critically Ill Adults N Engl J Med, 2018.PMID 29768150
- [17]Dell'Anna AM, Grieco DL, Dominedò C, et al. Stewart's theory and acid-base changes induced by crystalloid infusion in humans: a randomized physiological trial Ann Intensive Care, 2025.PMID 40263186
- [18]Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA, 2016.PMID 26903338
- [19]Spasovski G. Hyponatraemia-treatment standard 2024 Nephrol Dial Transplant, 2024.PMID 39009016
- [20]Chauhan K, Pattharanitima P, Patel N, et al. Rate of Correction of Hypernatremia and Health Outcomes in Critically Ill Patients Clin J Am Soc Nephrol, 2019.PMID 30948456
- [21]Long B, Warix JR, Koyfman A. Controversies in Management of Hyperkalemia J Emerg Med, 2018.PMID 29731287
- [22]Kim HJ, Han SW. Therapeutic approach to hyperkalemia Nephron, 2002.PMID 12401936
- [23]Aljabri A, Perona S, Alshibani M, et al. Blood glucose reduction in patients treated with insulin and dextrose for hyperkalaemia Emerg Med J, 2020.PMID 31653693
- [24]Allon M, Dunlay R, Copkney C. Nebulized albuterol for acute hyperkalemia in patients on hemodialysis Ann Intern Med, 1989.PMID 2919849
- [25]Jessen MK, Andersen LW, Djakow J, et al. Pharmacological interventions for the acute treatment of hyperkalaemia: A systematic review and meta-analysis Resuscitation, 2025.PMID 39761907
- [26]Geldermann N, Dzimiera J, Fischer H, et al. Acute hyperkalaemia in emergency care: evidence-based approaches Emerg Med J, 2026.PMID 41506858
- [27]Tzivoni D, Banai S, Schuger C, et al. Treatment of torsade de pointes with magnesium sulfate Circulation, 1988.PMID 3338130
- [28]al-Ghamdi SM, Cameron EC, Sutton RA. Magnesium deficiency: pathophysiologic and clinical overview Am J Kidney Dis, 1994.PMID 7977315
- [29]Figge J, Jabor A, Kazda A, et al. Anion gap and hypoalbuminemia Crit Care Med, 1998.PMID 9824071
- [30]Hoorn EJ, Zietse R. Diagnosis and Treatment of Hyponatremia: Compilation of the Guidelines J Am Soc Nephrol, 2017.PMID 28174217
- [31]Buffington MA, Abreo K. Hyponatremia: A Review J Intensive Care Med, 2016.PMID 25592330
- [32]Ambati R, Kho LK, Prentice D. Osmotic demyelination syndrome: novel risk factors and proposed pathophysiology Intern Med J, 2023.PMID 35717664
- [33]Singh TD, Fugate JE, Rabinstein AA. Central pontine and extrapontine myelinolysis: a systematic review Eur J Neurol, 2014.PMID 25220878
- [34]MacMillan TE, Cavalcanti RB. Outcomes in Severe Hyponatremia Treated With and Without Desmopressin Am J Med, 2018.PMID 29061503
- [35]Baeg SI, Lee K, Jeon J, et al. Management for Electrolytes Disturbances during Continuous Renal Replacement Therapy Electrolyte Blood Press, 2022.PMID 36688209
- [36]Hendrix RJ, Hastings MC, Samarin M, et al. Predictors of Hypophosphatemia and Outcomes during Continuous Renal Replacement Therapy Blood Purif, 2020.PMID 32320987
- [37]Viera AJ, Wouk N. Potassium Disorders: Hypokalemia and Hyperkalemia Am Fam Physician, 2015.PMID 26371733
- [38]Grout S, Maue D, Berrens Z, et al. Diabetic Ketoacidosis With Refractory Hypokalemia Leading to Cardiac Arrest Cureus, 2022.PMID 35494963
- [39]Thomas SH, Behr ER. Pharmacological treatment of acquired QT prolongation and torsades de pointes Br J Clin Pharmacol, 2016.PMID 26183037
- [40]Hofmann P, Risch M, Fehr T. [Albumin-corrected calcium]. Praxis, 2025.PMID 39964376
- [41]Assefi M, Leurent A, Blanchard F, et al. Impact of increasing post-filter ionized calcium target on filter lifespan in renal replacement therapy with regional citrate anticoagulation: A before-and-after study J Crit Care, 2023.PMID 37379797
- [42]Chen S, Shieh M, Chiaramonte R. Improving on the Adrogué-Madias Formula Kidney360, 2021.PMID 35373033
- [43]Knochel JP. Hypophosphatemia West J Med, 1981.PMID 7010790